glp-1 heart attack The cardiovascular effects of receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action How GLP-1 Medications Reduce Heart
Description
Only a small minority, fewer than 10%, say usage of GLP-1s is viewed positively
With flexible access and up to 10 CPD hours available, its tailored for clinicians seeking updates without leaving practice
Poston et al
Yasmine Abdel US 1 review Apr 4, 2025 Individual results may vary
Truveta Data, the most complete, timely, and clean electronic health record (EHR) data, includes more than 120 million de-identified patients more than one-third of the U.S
Early studies suggest semaglutide may help with PMOS-related symptoms like insulin resistance and body size, as well as BMI and waist circumference
